For pancreatic ductal adenocarcinoma (PDAC), two IHC markers, hepatocyte nuclear factor‐1A (HNF1A) and cytokeratin‐81 (KRT81), have emerged as practical surrogates for defining relevant PDAC subgroups [1, 2, 3]. This evidence concerns the gene KRT81 and pancreatic ductal adenocarcinoma.